ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

ClinicalTrials.gov ID: NCT02486718

Public ClinicalTrials.gov record NCT02486718. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 3:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Open-Label, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Best Supportive Care Following Adjuvant Cisplatin-Based Chemotherapy in Patients With Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer

Study identification

NCT ID
NCT02486718
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,280 participants

Conditions and interventions

Interventions

  • Atezolizumab Drug
  • Cisplatin Drug
  • Docetaxel Drug
  • Gemcitabine Drug
  • Pemetrexed Drug
  • Vinorelbine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 30, 2015
Primary completion
Jan 25, 2024
Completion
Aug 30, 2027
Last update posted
Apr 29, 2026

2015 – 2027

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Highlands Oncology Group Fayetteville Arkansas 72703
California Cancer Associates for Research & Excellence, Inc. Encinitas California 92024
Compassionate Cancer Care Medical Group, Inc Fountain Valley California 92708
University of California Los Angeles Los Angeles California 90024
Kaiser Permanente Vallejo California 94589
Kaiser Permanente - Walnut Creek Walnut Creek California 94596
Eastern Connecticut Hematology and Oncology Associates Norwich Connecticut 06360
Lynn Cancer Institute - West Boca Raton Florida 33486
University of Miami School of Medicine - Sylvester at Deerfield Deerfield Beach Florida 33442
SCRI Florida Cancer Specialists North St. Petersburg Florida 33705
Lewis Hall Singletary Oncology Center Thomasville Georgia 31792
University of Illinois at Chicago Chicago Illinois 60612
Illinois Cancer Care Peoria Illinois 61615
Norton Cancer Institute Louisville Kentucky 40402
St. Luke's Cancer Institute Kansas City Missouri 64111
Hematology Oncology Associates of Northern New Jersey Florham Park New Jersey 07932
Saint Barnabas Medical Center Livingston New Jersey 07039
Valley Hospital Paramus New Jersey 07652
Overlook Medical Center Summit New Jersey 07901
Clinical Research Alliance Lake Success New York 11042
Weill Cornell Medical College New York New York 10065
Presbyterian Hospital Charlotte North Carolina 28204
University of Cincinnati Cincinnati Ohio 45219
Oncology Hematology Care - SCRI Cincinnati Ohio 45242
Oregon Health and Science University Portland Oregon 97239
University Oncology Associates Chattanooga Tennessee 37403
Houston Methodist Cancer Center Houston Texas 77030
Wellmont Medical Associates Bristol Virginia 24201
Hematology Oncology Associates of Fredericksburg, Inc. Fredericksburg Virginia 22408
MultiCare Regional Cancer Center - Auburn Auburn Washington 98002-4117
Providence Everett Med Ctr Everett Washington 98201
Swedish Medical Center Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 122 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02486718, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02486718 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →